Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 51, 2022 - Issue 2
2,083
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Increased Peripheral NKG2A-NKG2D+CD3-CD16+CD56dim NK Cell Subset Was Positively Correlated with Antiphospholipid Antibodies in Patients of Obstetric Antiphospholipid Syndrome

, , , , , & show all

References

  • Abel AM, Yang C, Thakar MS, Malarkannan S. 2018. Natural killer cells: development, maturation, and clinical utilization. Front Immunol. 9:1869.
  • Antovic A, Sennstrom M, Bremme K, Svenungsson E. 2018. Obstetric antiphospholipid syndrome. Lupus Sci Med. 5(1):e000197.
  • Carolis SD, Tabacco S, Rizzo F, Giannini A, Botta A, Salvi S, Garufi C, Panici PB, Lanzone A. 2018. Antiphospholipid syndrome: an update on risk factors for pregnancy outcome. Autoimmun Rev. 17(10):956–66.
  • Chaturvedi S, McCrae RK. 2017. Diagnosis and management of the antiphospholipid syndrome. Blood Rev. 31:406–17.
  • Chrysoula D, Linda CG. 2005. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 26:44–62.
  • Cochery-Nouvellon E, Mercier E, Bouvier S, Balducchi JP, Quere I, Perez-Martin A, Mousty E, Letouzey V, Gris JC. 2017. Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes. Haematologica. 102:835–42.
  • De Carolis C, Perricone C, Perricone R. 2009. NK cells, autoantibodies, and immunologic infertility: a complex interplay. Clin Rev Allergy Immunol. 39:166–75.
  • Domaica CI, Fuertes MB, Uriarte I, Girart MV, Sardanons J, Comas DI, Di Giovanni D, Gaillard MI, Bezrodnik L, Zwirner NW. 2012. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development. PloS One. 7:e51677.
  • Esteve-Valverde E, Ferrer-Oliveras R, Alijotas-Reig J. 2016. Obstetric antiphospholipid syndrome. Rev Clín Esp (English Edition). 216:135–45.
  • Fan X, Zhu L, Liang H, Xie Z, Huang X, Wang S, Shen T. 2016. Antibody-dependent CD56+ T cell responses are functionally impaired in long-term HIV-1 infection. Retrovirology. 13:76.
  • Fan YY, Yang BY, Wu CY. 2008. Phenotypic and functional heterogeneity of natural killer cells from umbilical cord blood mononuclear cells. Immunol Invest. 37:79–96.
  • Fu B, Tian Z, Wei H. 2014. Subsets of human natural killer cells and their regulatory effects. Immunology. 141:483–89.
  • Fu B, Wang F, Sun R, Ling B, Tian Z, Wei H. 2011. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology. 133:350–59.
  • Fu B, Zhou Y, Ni X, Tong X, Xu X, Dong Z, Sun R, Tian Z, Wei H. 2017. Natural killer cells promote fetal development through the secretion of growth-promoting factors. Immunity. 47:1100–13.
  • Hernández-Molina G, Espericueta-Arriola G, Cabral AR. 2013. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome. Clin Exp Rheumatol. 31:382–88.
  • Kitaya K. 2008. Accumulation of uterine CD16(-) natural killer (NK) cells: friends, foes, or Jekyll-and-Hyde relationship for the conceptus? Immunol Invest. 37:467–81.
  • Kumar S. 2018. Natural killer cell cytotoxicity and its regulation by inhibitory receptors. Immunology. 154:383–93.
  • Lash GE, Robson SC, Bulmer JN. 2010. Review: functio nal role of uterine natural killer (uNK) cells in human early pregnancy decidua. Trophoblast Res. 24:S87–S92.
  • Lee CL, Vijayan M, Wang X, Lam KKW, Koistinen H, Seppala M, Li RHW, Ng EHY, Yeung WSB, Chiu PCN. 2019. Glycodelin-A stimulates the conversion of human peripheral blood CD16-CD56bright NK cell to a decidual NK cell-like phenotype. Hum Reprod. 34:689–701.
  • Liu L, Sun D. 2019. Pregnancy outcomes in patients with primary antiphospholipid syndrome: A systematic review and meta-analysis. Medicine. 98:e15733.
  • Marchetti T, Cohen M, de Moerloose P. 2013. Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implications. Clin Dev Immunol. 2013:159124.
  • Pengo V, Banzato A, Denas E, Bison G, Padayattil Jose S, Ruffatti A. 2010. Antiphospholipid syndrome: critical analysis of the diagnostic path. Lupus. 19:428–31.
  • Perricone C, De Carolis C, Giacomelli R, Zaccari G, Cipriani P, Bizzi E, Perricone R. 2007. High levels of NK cells in the peripheral blood of patients affected with anti-phospholipid syndrome and recurrent spontaneous abortion: a potential new hypothesis. Rheumatology. 46:1574–78.
  • Rubin TS, Zhang KJ, Gifford C, Lane A, Choo S, Bleesing JJ, Marsh RA. 2017. Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH. BLOOD. 129:2993–99.
  • Ryan JC, Naper C, Hayashi S, Daws MR. 2001. Physiologic functions of activating natural killer (NK) complex-encoded receptors on NK cells. Immunol Rev. 181:126–37.
  • Tabiasco J, Rabot M, Aguerre-Girr M, El Costa H, Berrebi A, Parant O, Laskarin G, Juretic K, Bensussan A, Rukavina D, et al. 2006. Human decidual NK cells: unique phenotype and functional properties – a review. Placenta. 27(Suppl A):S34–9.
  • Van den Hoogen LL, van Roon JAG, Radstake TRDJ, Fritsch-Stork RDE, Derksen RHWM. 2016. Delineating the deranged immune system in the antiphospholipid syndrome. Autoimmun Rev. 15:50–60.
  • Yougbare I, Tai WS, Zdravic D, Oswald BE, Lang S, Zhu G, Leong-Poi H, Qu D, Yu L, Dunk C, et al. 2017. Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia. Nat Commun. 8:224.
  • Zhang QF, Yin WW, Xia Y, Yi YY, He QF, Wang X, Ren H, Zhang DZ. 2017. Liver-infiltrating CD11b(-)CD27(-) NK subsets account for NK-cell dysfunction in patients with hepatocellular carcinoma and are associated with tumor progression. Cell Mol Immunol. 14:819–29.
  • Zhang Y, Zhao A, Wang X, Shi G, Jin H, Lin Q. 2008. Expressions of natural cytotoxicity receptors and NKG2D on decidual natural killer cells in patients having spontaneous abortions. Fertil Steril. 90:1931–37.